Your browser is no longer supported. Please, upgrade your browser.
HOLX Hologic, Inc. monthly Stock Chart
HOLX [NASD]
Hologic, Inc.
IndexS&P 500 P/E36.41 EPS (ttm)1.87 Insider Own0.80% Shs Outstand259.87M Perf Week1.51%
Market Cap17.33B Forward P/E15.81 EPS next Y4.30 Insider Trans-12.16% Shs Float257.90M Perf Month7.78%
Income496.80M PEG2.22 EPS next Q1.20 Inst Own97.50% Short Float1.44% Perf Quarter8.33%
Sales3.30B P/S5.26 EPS this Y55.70% Inst Trans-0.04% Short Ratio1.73 Perf Half Y37.16%
Book/sh8.68 P/B7.82 EPS next Y38.50% ROA7.50% Target Price78.21 Perf Year42.43%
Cash/sh2.92 P/C23.29 EPS next 5Y16.40% ROE22.80% 52W Range26.49 - 73.63 Perf YTD30.07%
Dividend- P/FCF26.95 EPS past 5Y-69.20% ROI-1.30% 52W High-7.77% Beta1.41
Dividend %- Quick Ratio1.20 Sales past 5Y5.90% Gross Margin53.90% 52W Low156.36% ATR1.79
Employees6478 Current Ratio1.50 Sales Q/Q-3.50% Oper. Margin11.70% RSI (14)55.14 Volatility2.42% 2.44%
OptionableYes Debt/Eq1.47 EPS Q/Q52.30% Profit Margin15.10% Rel Volume0.48 Prev Close67.97
ShortableYes LT Debt/Eq1.22 EarningsNov 04 AMC Payout0.00% Avg Volume2.15M Price67.91
Recom1.70 SMA201.34% SMA504.98% SMA20024.49% Volume1,029,304 Change-0.09%
Jun-30-20Upgrade Cowen Market Perform → Outperform $64
Jun-03-20Upgrade Raymond James Mkt Perform → Outperform $62
Apr-30-20Upgrade SVB Leerink Mkt Perform → Outperform $62
Apr-30-20Reiterated Needham Buy $52 → $60
Apr-07-20Upgrade Wells Fargo Equal Weight → Overweight $48
Mar-27-20Upgrade Morgan Stanley Underweight → Equal-Weight $40
Mar-27-20Downgrade Morgan Stanley Overweight → Equal-Weight $24
Jan-13-20Reiterated Needham Buy $57 → $62
Jan-08-20Initiated Wells Fargo Equal Weight $57
Jan-07-20Initiated Citigroup Buy $60
Jan-02-20Downgrade Evercore ISI Outperform → In-line
Sep-26-19Upgrade BofA/Merrill Neutral → Buy $54 → $59
Aug-01-19Reiterated Needham Buy $52 → $57
May-02-19Reiterated Needham Buy $50 → $52
Jan-31-19Reiterated Needham Buy $48 → $50
Jan-02-19Downgrade Morgan Stanley Equal-Weight → Underweight
Oct-09-18Initiated UBS Neutral
Sep-13-18Downgrade BofA/Merrill Buy → Neutral
Aug-01-18Reiterated Needham Buy $43 → $48
May-03-18Reiterated Needham Buy $50 → $43
Oct-22-20 09:27PM  
Oct-21-20 09:00AM  
Oct-20-20 08:15AM  
Oct-19-20 07:52PM  
Oct-17-20 04:53AM  
04:29AM  
03:44AM  
01:08AM  
Oct-13-20 09:55AM  
Oct-07-20 04:04PM  
08:22AM  
07:30AM  
Oct-06-20 04:03PM  
11:33AM  
Oct-01-20 04:02PM  
Sep-30-20 10:11AM  
08:57AM  
Sep-28-20 09:23AM  
08:50AM  
08:16AM  
08:00AM  
Sep-22-20 05:00PM  
Sep-21-20 01:42PM  
Sep-18-20 09:56AM  
Sep-15-20 10:01AM  
Sep-14-20 06:52PM  
11:47AM  
08:06AM  
08:01AM  
Sep-11-20 08:14AM  
Sep-08-20 10:40AM  
Sep-07-20 05:10AM  
Sep-04-20 04:02PM  
Sep-01-20 04:56PM  
Aug-31-20 12:33PM  
08:59AM  
Aug-28-20 11:43AM  
11:31AM  
Aug-27-20 03:39PM  
08:50AM  
06:30AM  
Aug-26-20 11:31AM  
01:57AM  
Aug-25-20 04:02PM  
Aug-21-20 10:56AM  
Aug-18-20 09:00AM  
Aug-14-20 10:42AM  
Aug-12-20 09:54AM  
Aug-11-20 09:50AM  
08:02AM  
07:15AM  
Aug-10-20 08:20AM  
Aug-07-20 02:57PM  
Aug-06-20 04:22PM  
10:21AM  
08:32AM  
Aug-05-20 12:01PM  
10:34AM  
09:52AM  
Aug-04-20 11:40AM  
10:40AM  
10:28AM  
Aug-03-20 08:08AM  
Jul-31-20 08:00AM  
06:54AM  
Jul-30-20 09:20AM  
12:03AM  
Jul-29-20 05:47PM  
05:15PM  
04:30PM  
04:01PM  
07:32AM  
Jul-28-20 01:56PM  
Jul-27-20 07:00AM  
Jul-23-20 03:11PM  
Jul-22-20 12:32PM  
09:00AM  
08:59AM  
05:30AM  
Jul-15-20 06:43PM  
Jul-10-20 01:01PM  
10:23AM  
Jul-08-20 12:40PM  
08:08AM  
Jul-06-20 10:04AM  
Jul-02-20 08:15AM  
Jul-01-20 09:45AM  
Jun-30-20 02:31PM  
02:22PM  
11:12AM  
10:40AM  
09:54AM  
Jun-29-20 11:40AM  
11:27AM  
09:44AM  
08:28AM  
Jun-26-20 10:03AM  
09:14AM  
Jun-25-20 12:35PM  
10:34AM  
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, surgical products, and light-based aesthetic and medical treatment systems for women in the United States and internationally. The company offers Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima quantitative viral load tests for HIV, Hepatitis C, and Hepatitis B; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for acute respiratory ailments. It also provides breast imaging and analytics, such as 2D and 3D mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company offers aesthetic treatment systems, as well as TempSure, a radio frequency energy-sourced platform, which offers non-surgical and surgical aesthetic treatments and procedures. Further, it offers NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Additionally, the company offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. has a collaboration with RadNet, Inc. to advance the use of artificial intelligence in breast health. The company was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Oberton Karleen MarieChief Financial OfficerSep 22Option Exercise26.215,461143,13334,417Sep 23 04:21 PM
Oberton Karleen MarieChief Financial OfficerSep 21Option Exercise26.2115,000393,15043,956Sep 23 04:21 PM
Oberton Karleen MarieChief Financial OfficerSep 21Sale62.5015,000937,50028,956Sep 23 04:21 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerAug 03Option Exercise23.822,98671,12719,699Aug 05 05:49 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerAug 03Sale71.244,924350,81016,713Aug 05 05:49 PM
Valenti Peter J. IIIDivision Pres., Breast HealthJun 30Option Exercise26.2110,493275,02270,484Jul 02 04:04 PM
Valenti Peter J. IIIDivision Pres., Breast HealthJun 30Sale54.0710,493567,35759,991Jul 02 04:04 PM
Valenti Peter J. IIIDivision Pres., Breast HealthMay 22Option Exercise26.2110,493275,02270,484May 27 04:12 PM
Valenti Peter J. IIIDivision Pres., Breast HealthMay 22Sale51.8210,493543,77959,991May 27 04:12 PM
CRAWFORD SALLYDirectorMay 22Sale51.9931,9501,661,081126,847May 27 04:09 PM
Thornal Kevin RDiv. President, DiagnosticsMay 15Option Exercise26.0113,888361,22730,914May 19 04:09 PM
Thornal Kevin RDiv. President, DiagnosticsMay 15Sale51.5113,888715,42617,026May 19 04:09 PM
MACMILLAN STEPHEN PChairman, President and CEOMay 13Option Exercise22.29215,9964,814,5511,913,438May 15 04:17 PM
MACMILLAN STEPHEN PChairman, President and CEOMay 13Sale50.97190,9969,735,2571,722,442May 15 04:17 PM
GARRETT SCOTT TDirectorMay 01Option Exercise20.3424,204492,30951,385May 05 04:16 PM
Griffin John M.General CounselApr 28Option Exercise32.384,906158,85698,080Apr 30 04:07 PM
Griffin John M.General CounselApr 28Sale50.004,906245,30095,307Apr 30 04:07 PM
CRAWFORD SALLYDirectorMar 09Option Exercise22.3511,146249,113169,943Mar 11 04:07 PM
CRAWFORD SALLYDirectorMar 09Sale44.0811,146491,317158,797Mar 11 04:07 PM
MACMILLAN STEPHEN PChairman, President and CEOFeb 03Option Exercise22.29215,9964,814,5511,891,838Feb 05 04:16 PM
MACMILLAN STEPHEN PChairman, President and CEOFeb 03Sale53.54194,39610,407,1841,697,442Feb 05 04:16 PM
Griffin John M.General CounselJan 13Option Exercise33.6819,624661,021106,399Jan 15 05:59 PM
Griffin John M.General CounselJan 13Sale52.8619,6241,037,33495,307Jan 15 05:59 PM
Oberton Karleen MarieChief Financial OfficerJan 02Option Exercise22.3216,348364,82145,304Jan 06 04:06 PM
Oberton Karleen MarieChief Financial OfficerJan 02Sale51.7316,348845,68728,956Jan 06 04:06 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerDec 04Option Exercise21.454,37993,93022,541Dec 05 04:11 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerDec 04Sale52.124,379228,22518,162Dec 05 04:11 PM
Stamoulis ChristianaDirectorNov 22Option Exercise20.0112,306246,24349,481Nov 26 04:10 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerNov 22Option Exercise21.454,40094,38023,063Nov 26 04:15 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerNov 22Sale50.094,400220,40018,663Nov 26 04:15 PM
Stamoulis ChristianaDirectorNov 22Sale49.7512,306612,22437,175Nov 26 04:10 PM
MACMILLAN STEPHEN PChairman, President and CEONov 11Option Exercise22.29215,9964,814,5511,781,811Nov 13 05:31 PM
MACMILLAN STEPHEN PChairman, President and CEONov 11Sale45.91194,3968,924,6511,587,415Nov 13 05:31 PM
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 FINVIZ.com. All Rights Reserved.